Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Harmony Biosciences faces FDA setback for pitolisant in idiopathic hypersomnia Harmony Biosciences Holdings, Inc. has encountered a regulatory hurdle in its efforts to expand the use of pitolisant… byPallavi MadhirajuFebruary 20, 2025